Mont-Saint-Guibert, Belgium - Celyad (Euronext Brussels and Paris, and NASDAQ:CYAD), a pioneer in the discovery and development of CAR-T cell therapies, today announced that Patrick Jeanmart, Chief Financial Officer and David Gilham, VP Research and Development of Celyad will present a corporate update at the upcoming 29 Annual Piper Jaffray Healthcare Conference on Tuesday, November 28, 2017 at 4:30 p.m. ET in New York, NY.

A live audio webcast of the presentation will be available on the Investor Relations section of Celyad's website at www.celyad.com/en/investors, where it will be archived for approximately 90 days.

Celyad SA published this content on 21 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 21 November 2017 15:18:02 UTC.

Original documenthttps://www.celyad.com/en/news/celyad-to-present-at-the-29th-annual-piper-jaffray-healthcare-conference

Public permalinkhttp://www.publicnow.com/view/CEAD028E2DA96B5EEDE053AC7851C65870EE6014